MedPath

Radical Cystectomy, Nutrition and Convalescence

Not Applicable
Completed
Conditions
Urinary Bladder Neoplasms
Bladder Cancer
Cystectomy
Interventions
Dietary Supplement: Parenteral nutrition. SMOFKABIVEN infusion in central vene. Fresenius Kabi
Registration Number
NCT02238886
Lead Sponsor
Rigshospitalet, Denmark
Brief Summary

The purpose of this study is to determine whether a goal directed nutritional intervention can reduce the convalescence period for patients undergoing radical cystectomy (RC).

The aim is to examine the effect on quality of life of a standard nutritional strategy of resting the bowel till clear signs of bowel recovery and feeding orally after bowel recovery versus a goal-directed nutritional intervention combining oral intake and parenteral nutrition, in patients undergoing RC.

Detailed Description

The study is a randomized controlled trial. Inclusion criteria: Bladder cancer, ability to give an informed consent. Exclusion criteria: Previous radiation therapy at the pelvic area, ureterocutaneostomy or robot-assisted surgery. The intervention aims to secure that 75% of the patient's total energy and protein needs are met during hospitalization.

Primary outcome: Quality of Life, using the EORTC QLQ-C30 and BLM30 questionnaire. Secondary outcomes: Body-weight, Hand Grip strength, biochemical measures, length of hospital stay, time to bowel recovery. The follow-up period is 12 weeks. Statistical analysis is performed in collaboration with a statistician.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Bladder cancer
  • Ability to give an informed consent
Exclusion Criteria
  • Previous radiation therapy at the pelvic area
  • Ureterocutaneostomy
  • Robot-assisted surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Parenteral nutritionParenteral nutrition. SMOFKABIVEN infusion in central vene. Fresenius KabiPatients receives a goal-directed nutritional intervention combining oral intake and parenteral nutrition
Primary Outcome Measures
NameTimeMethod
Health related quality of life (HRQoL) using the EORTC QLQ-C30 and BLM30 (one combined questionnaire)meassured pre-operatively + 6 and 12 weeks following surgery

Change from baseline HRQoL at 6 and 12 weeks following surgery

Secondary Outcome Measures
NameTimeMethod
length of hospital stay12 week follow-up
Time to bowel recovery12 week follow-up
Body weightpreoperatively, 6 and 12 weeks postop

Change from baseline weight at 6 and 12 weeks following the date of surgery

hand grip strengthpre-operatively, 6 days and 6 weeks postop

Change from baseline hand grip strength at 6 days and 6 weeks following the date of surgery

Trial Locations

Locations (1)

Dep. of Urology. University Hospital Rigshospitalet, Copenhagen Denmark

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath